News

BioM's articles and press releases about the Bavarian biotechnology sector


Formycon and Fresenius Kabi receive EU approval for FYB202/Otulfi® (ustekinumab) for the treatment of inflammatory diseases

For­my­con AG from Martin­sried near Mu­nich and its com­mer­cial­iz­a­tion part­ner Freseni­us Kabi have re­ceived ap­prov­al from the…

m4 Award winner knowing01 receives oversubscribed pre-seed funding

The Mu­nich-based bi­otech SaaS start-up know­ing01 GmbH has suc­cess­fully com­pleted an over­sub­scribed six-fig­ure pre-seed fin­an­cing…

Pentixapharm from Würzburg/Berlin sets price range for planned IPO

Pentixapharm Hold­ing AG, fo­cused on the de­vel­op­ment of first-in-class ra­dio­phar­ma­ceut­ic­als, has an­nounced the price range for…

New Max Planck Center for Physics and Medicine opened in Erlangen

The grand open­ing of the Max Planck Center for Phys­ics and Medi­cine (MPZPM) in Er­lan­gen took place on Septem­ber 20, 2024. Around 120…

Eisbach starts Phase 1/2 trial of EIS-12656 in advanced solid tumours: first patient treated

Eis­bach Bio GmbH, a privately held clin­ic­al-stage bi­o­tech­no­logy com­pany fo­cused on can­cer medi­cines lever­aging syn­thet­ic…

Spin-off with the m4 Award - 8th call now open

You are an aca­dem­ic re­search team in the field of bio­medi­cine and want to spin off? Then the m4 Award is the per­fect op­por­tun­ity…

Project funding BaCaTeC - NEW: Doubling to EUR 20,000!

The Bav­aria Cali­for­nia Tech­no­logy Center (BaCaTeC) pro-motes the co­oper­a­tion of re­search fa­cil­it­ies in Bav­aria and Cali­for­nia…

Healthcare Hackathon Bavaria 2024 – Hack for health!

Are you ready to re­vo­lu­tion­ize the health­care sec­tor in Ger­many with in­nov­at­ive ideas? The Health­care Hack­a­thon of­fers you…

BIO International 2025: Secure your spot at the German pavilion!

The BIO In­ter­na­tion­al Con­ven­tion will take place from June 16 to 19, 2025 in Bo­ston (USA). With around 20,000 par­ti­cipants, the…

IRUBIS secures Pre-Series A funding to accelerate bioprocess development

Mu­nich-based bi­otech star­tup IRUBIS, which is de­vel­op­ing a state-of-the-art real-time solu­tion for biopro­cess mon­it­or­ing, has…